Company / Cost of Revenue
Quest Diagnostics Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$7.4B
FY2025
5-year range
$5.0B / $7.4B
FY2021-FY2025
Trend
+11.2%
vs FY2024
Sector context
#17 of 113
Health Care
What the data says
Quest Diagnostics's cost of revenue of $7.4B is higher than 85% of companies in the Health Care sector (FY2025). Cost of Revenue has increased for 4 consecutive years, from $5.0B in FY2021 to $7.4B in FY2025.
Based on SEC 10-K filings.
$7.4B in FY2025 with a 5-year CAGR of +4.9%. Top quartile in the Health Care sector.
Increased from $6.6B to $7.4B over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +8.3%
- 5-Year CAGR
- +4.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 113This company $7.4B Sector average $11.3B
▼
-34.8% below sector average
Key checks
Key Insights
- Quest Diagnostics's cost of revenue has grown for 4 consecutive years.
- 5-year CAGR of +4.9%, indicating consistent growth.
- In FY2025, cost of revenue increased 11.2% year-over-year.
- Ranks #17 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.4B | +11.2% |
| FY2024 | $6.6B | +0.7% |
| FY2023 | $6.6B | +13.4% |
| FY2022 | $5.8B | +15.2% |
| FY2021 | $5.0B | -13.2% |
| FY2020 | $5.8B | +23.0% |
| FY2019 | $4.7B | +2.2% |
| FY2018 | $4.6B | -0.9% |
| FY2017 | $4.7B | +0.4% |
| FY2016 | $4.6B | +7.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026